In clinical trials phase II, 20 mg of lycopene reduced the skin toxicity of metastasis CRC patients with panitumumab treatment. In this study 28 patients received with anti-EGFR inhibitor were participated for 12 weeks. This evidence concerns the gene EGFR and colorectal carcinoma.